These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16901975
1. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT. J Clin Pathol; 2007 Jun; 60(6):642-8. PubMed ID: 16901975 [Abstract] [Full Text] [Related]
2. Potential role of leptin expression in hepatocellular carcinoma. Wang SN, Yeh YT, Yang SF, Chai CY, Lee KT. J Clin Pathol; 2006 Sep; 59(9):930-4. PubMed ID: 16565221 [Abstract] [Full Text] [Related]
3. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, Nabika T, Nagasue N. Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326 [Abstract] [Full Text] [Related]
4. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. J Surg Oncol; 2008 Oct 01; 98(5):349-57. PubMed ID: 18646041 [Abstract] [Full Text] [Related]
5. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Clin Cancer Res; 2003 Nov 01; 9(14):5339-45. PubMed ID: 14614019 [Abstract] [Full Text] [Related]
6. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, Nakamura M, Yoshioka S, Kato H, Damdinsuren B, Tang D, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Sakon M, Dono K, Wakasa K, Monden M. Liver Int; 2006 May 01; 26(4):414-23. PubMed ID: 16629644 [Abstract] [Full Text] [Related]
7. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J. Gut; 2010 Jul 01; 59(7):953-62. PubMed ID: 20442200 [Abstract] [Full Text] [Related]
8. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma]. Xiao G, Zhang WM, Zhang M, Xie D, Guo AL, Wen JM. Ai Zheng; 2005 Jan 01; 24(1):99-103. PubMed ID: 15642211 [Abstract] [Full Text] [Related]
9. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Clin Cancer Res; 2003 Feb 01; 9(2):594-600. PubMed ID: 12576423 [Abstract] [Full Text] [Related]
10. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Moon WS, Rhyu KH, Kang MJ, Lee DG, Yu HC, Yeum JH, Koh GY, Tarnawski AS. Mod Pathol; 2003 Jun 01; 16(6):552-7. PubMed ID: 12808060 [Abstract] [Full Text] [Related]
11. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A. Exp Mol Pathol; 2009 Dec 01; 87(3):167-72. PubMed ID: 19686732 [Abstract] [Full Text] [Related]
12. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, Xie K, Sawaya R, Huang S. Clin Cancer Res; 2005 Feb 15; 11(4):1386-93. PubMed ID: 15746037 [Abstract] [Full Text] [Related]
13. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH. J Clin Pathol; 2008 May 15; 61(5):658-64. PubMed ID: 17908805 [Abstract] [Full Text] [Related]
14. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H. Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839 [Abstract] [Full Text] [Related]
15. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N. Cancer; 2005 Feb 01; 103(3):588-98. PubMed ID: 15612021 [Abstract] [Full Text] [Related]
16. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY. Hepatobiliary Pancreat Dis Int; 2005 May 01; 4(2):220-6. PubMed ID: 15908319 [Abstract] [Full Text] [Related]
17. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Zhao WB, Li Y, Liu X, Zhang LY, Wang X. Int J Mol Med; 2008 Aug 01; 22(2):187-92. PubMed ID: 18636172 [Abstract] [Full Text] [Related]
18. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. J Pathol; 2001 Jan 01; 193(1):95-101. PubMed ID: 11169521 [Abstract] [Full Text] [Related]
19. [A study on vasculogenic mimicry in hepatocellular carcinoma]. Zhao XL, Du J, Zhang SW, Liu YX, Wang X, Sun BC. Zhonghua Gan Zang Bing Za Zhi; 2006 Jan 01; 14(1):41-4. PubMed ID: 16420764 [Abstract] [Full Text] [Related]
20. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M. Ann Surg Oncol; 2007 Mar 01; 14(3):1191-9. PubMed ID: 17195907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]